论文部分内容阅读
通常采用针对病因或对症的治疗原则治疗耳鸣均难以奏效。纵然助听器常可缓解伴有听力减退者的耳鸣,生物学反馈、声学掩蔽以及各种药物也报告有一定效果,但仍有相当比例患者的耳鸣不能解除。本文作者应用配戴式经皮(表面电极)电子耳鸣抑制器(ETS)对20名参试的耳鸣伴感音神经性聋患者行双盲、安慰-对照研究,目的在于证实已报告的电子刺激器对耳鸣的效果。由厂方提供有效和内部线路中断的无效ETS各5只,受试者于第一周和第4周配戴有效及无效EBS各一周,中间休息两周,有效及无效耳机的次序为随机安排。配戴时间:于试验周内,第一天为1小时,以后逐日增加1小时,至第5、6、7天均
It is often difficult to treat tinnitus with the principles of treatment for the cause or symptomatology. Although hearing aids can often relieve tinnitus in people with hearing loss, biological feedback, acoustic masking, and various medications are also reported to have some effect, tinnitus is still not resolved in a significant proportion of patients. The authors applied a wearable percutaneous (surface electrode) electronic tinnitus suppressor (ETS) to a double-blind, placebo-controlled study of 20 patients with tinnitus-associated sensorineural hearing loss in order to verify that the reported electronic stimulus The effect of tinnitus on the device. Five invalid ETSs were provided by the manufacturer for valid and internal line disruptions. Subjects wore valid and invalid EBS for the first week and the fourth week, followed by a two-week break. The order of valid and invalid earphones was randomized . Wear time: in the test week, the first day of 1 hour later increased 1 hour day to day 5,6,7 days